FDA-Inspected Site

Juno Therapeutics, Inc.

4 FDA inspections are on record for Juno Therapeutics, Inc. in Bothell, United States.

Clean· No action indicated

Bothell, United States · Last updated July 11, 2026

Overview

  • 4 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-11-04.

At a glance

Inspections

4

Form 483s

2

EIRs

1

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
27 Oct 2025 – 4 Nov 2025BiologicsClean
16 Sep 2024 – 24 Sep 2024BiologicsClean
11 Sep 2023 – 20 Sep 2023Human Drugs483View 483 →
7 Oct 2020 – 16 Oct 2020Biologics483On file

Observations on record

Form 483 observations cited at this site, most recent first.

20 Sep 2023
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Christopher R Czajka, Michael Araneta

20 Sep 2023
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Christopher R Czajka, Michael Araneta

20 Sep 2023
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Christopher R Czajka, Michael Araneta

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Juno Therapeutics, Inc.'s 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat